Assembly Biosciences Inc. (ASMB)
NASDAQ: ASMB
· Real-Time Price · USD
24.67
-0.86 (-3.37%)
At close: Sep 26, 2025, 3:59 PM
24.67
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT
Assembly Biosciences Revenue Breakdown
| Period Ending | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|
| License and Service Revenue | 1.2M | 1.2M |
| License and Service Revenue Growth | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.59M | 4.51M | 4.61M | 4.29M | 4.45M | 4.6M | 8.62M | 4.22M | 4.96M | 5.01M | 6.13M | 5.27M | 6.78M | 5.96M | 6.5M | 6.66M | 6.92M | 8.7M | 7.17M | 11.69M | 9.47M | 8.73M | 10.83M | 8.49M | 4.08M | 9.52M | 8.81M | 7.75M | 12.54M | 5.7M | 5M | 4.18M | 3.8M | 4.04M | 3.25M | 2.85M | 2.94M | 3.16M | 2.95M | 2.49M | 2.49M | 3.37M |
| Selling, General, and Administrative Revenue Growth | +1.89% | -2.17% | +7.54% | -3.58% | -3.43% | -46.63% | +104.17% | -14.92% | -0.94% | -18.17% | +16.20% | -22.27% | +13.83% | -8.41% | -2.27% | -3.79% | -20.53% | +21.39% | -38.66% | +23.43% | +8.49% | -19.43% | +27.64% | +108.04% | -57.13% | +8.08% | +13.59% | -38.20% | +120.22% | +13.96% | +19.57% | +9.96% | -5.91% | +24.48% | +14.06% | -3.04% | -7.08% | +7.05% | +18.40% | +0.24% | -26.20% | n/a |
| Research and Development Revenue | 16.13M | 14.85M | 14.28M | 13.52M | 16.26M | 11.88M | 11.01M | 10.82M | 12.52M | 14.55M | 16.85M | 18.13M | 17.79M | 17.2M | 14.75M | 18.47M | 16.75M | 18.55M | 33.51M | 26.94M | 23.33M | 23.05M | 22.62M | 21.74M | 18.7M | 22.7M | 21.25M | 19.11M | 17.84M | 14.54M | 10.6M | 10.93M | 12.13M | 10.57M | 8.62M | 8.83M | 7.52M | 8.12M | 5.23M | 4.63M | 4.67M | 3.83M |
| Research and Development Revenue Growth | +8.58% | +4.00% | +5.66% | -16.88% | +36.87% | +7.93% | +1.68% | -13.57% | -13.91% | -13.68% | -7.04% | +1.90% | +3.41% | +16.67% | -20.17% | +10.30% | -9.73% | -44.63% | +24.38% | +15.49% | +1.22% | +1.90% | +4.05% | +16.24% | -17.64% | +6.84% | +11.21% | +7.11% | +22.69% | +37.22% | -3.04% | -9.86% | +14.67% | +22.63% | -2.39% | +17.48% | -7.38% | +55.36% | +12.86% | -0.81% | +21.73% | n/a |